LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake

被引:10
作者
Chen, Xiaoli [1 ]
Wang, Lili [1 ]
Wang, Hui [1 ]
机构
[1] Sixth Peoples Hosp Qingdao, Areas Liver Dis 10, 9 Fushun Rd, Qingdao 266000, Shandong, Peoples R China
关键词
hepatocellular carcinoma; long intergenic non-protein coding RNA 1638; long non-coding RNA; glucose transporter 1; glucose uptake; EXPRESSION;
D O I
10.3892/ol.2019.10682
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to examine the function of long intergenic non-protein coding RNA 1638 (LINC01638) long non-coding RNA (lncRNA) in hepatocellular carcinoma (HCC). In the present study, gene expression was analyzed using qPCR and western blotting. Glucose uptake was analyzed using a glucose uptake assay and cell proliferation was analyzed using a cell counting kit-8 assay. LINC01638 lncRNA and glucose transporter 1 (GLUT1) were upregulated in tumor tissues compared with adjacent healthy tissues of patients with HCC. Expression levels of LINC01638 lncRNA and GLUT1 were positively correlated only in tumor tissues; however, there was no correlation in adjacent healthy tissues. Overexpression of LINC01638 lncRNA and GLUT1 promoted glucose uptake, while LINC01638 lncRNA and GLUT1-knockdown led to inhibited glucose uptake of cells of HCC cell lines. Overexpression of LINC01638 lncRNA mediated the upregulation of GLUT1 expression and accelerated cell proliferation. GLUT1 overexpression failed to significantly affect LINC01638 lncRNA expression, however also promoted cancer cell proliferation. In addition, GLUT1-knockdown attenuated the effects of LINC01638 overexpression on cancer cell proliferation. Therefore, LINC01638 lncRNA promoted cancer cell proliferation in HCC, potentially by increasing cancer cell glucose uptake.
引用
收藏
页码:3811 / 3816
页数:6
相关论文
共 50 条
[31]   Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer [J].
Shen, Yanfeng ;
Xi, Feng ;
Li, Haibin ;
Luo, Yin ;
Chen, Cheng ;
Wang, Lei .
IUBMB LIFE, 2018, 70 (07) :642-648
[32]   Regulatory roles of lncRNA PANDAR in breast cancer cell proliferation [J].
Sun, Qinnuan ;
Wang, Xiumei .
ASIAN BIOMEDICINE, 2021, 15 (06) :285-291
[33]   LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma [J].
Zhang, Hai-Feng ;
Li, Wei ;
Han, Yi-Di .
CANCER BIOMARKERS, 2018, 21 (03) :575-582
[34]   LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer [J].
Yu, Chun-Ling ;
Xu, Xiao-Ling ;
Yuan, Fang .
BIOSCIENCE REPORTS, 2019, 39
[35]   lncRNA CYTOR promotes cell proliferation and tumor growth via miR-125b/SEMA4C axis in hepatocellular carcinoma [J].
Tian, Qing ;
Yan, Xiaodong ;
Yang, Long ;
Liu, Zirong ;
Yuan, Zheyle ;
Zhang, Yamin .
ONCOLOGY LETTERS, 2021, 22 (05)
[36]   Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution [J].
Xiong, Guanying ;
Yang, Lihua ;
Chen, Yun ;
Fan, Zhining .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (11) :2262-2269
[37]   Id4 promotes cell proliferation in hepatocellular carcinoma [J].
Yang Zhang ;
LiXing Zhang ;
XiaoQin Liu ;
FangYu Zhao ;
Chao Ge ;
TaoYang Chen ;
Ming Yao ;
JinJun Li .
ChineseJournalofCancer, 2017, 36 (02) :88-98
[38]   Circular RNA circVAPA Promotes Cell Proliferation in Hepatocellular Carcinoma [J].
Liu, Caifeng ;
Zhong, Xingyang ;
Li, Jun ;
Xu, Feng .
HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2019, 30 (04) :152-159
[39]   Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma [J].
Ming-Qi Fan ;
Chi-Bing Huang ;
Yan Gu ;
Ya Xiao ;
Jin-Xin Sheng ;
Lin Zhong .
Journal of Experimental & Clinical Cancer Research, 32
[40]   Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma [J].
Fan, Ming-Qi ;
Huang, Chi-Bing ;
Gu, Yan ;
Xiao, Ya ;
Sheng, Jin-Xin ;
Zhong, Lin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32